• Medico-Economic Evaluation in Fran Methodology and Impact on the Pricing and Reimbursement System

    Nov 1, 2013, 00:00

  • Targeted Therapy in Triple-Negative Metastatic Breast Cancer (TNBC) - A Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • Health Economic Analysis of Pneumococcal Vaccination – Example from Bulgaria

    Nov 1, 2013, 00:00

  • Cost-Minimization of Mabthera Intravenous Versus Subcutaneous Administration

    Nov 1, 2013, 00:00

  • Health Related Quality of Life-Outcome in National Care - Real World Data from the German Psoriasis-Registry “Psobest”

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Costs Associated with Atypical Antipsychotics Use in Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Quebec, Canada

    Nov 1, 2013, 00:00

  • Placebo-Controlled Trials- Are They Acceptable to Health Technology Assessment Bodies?

    Nov 1, 2013, 00:00

  • Health Technology Assessments of Medical Devices- Is Help Out There?

    Nov 1, 2013, 00:00

  • Current and Future Strategy for Osteoporosis Screening and Diagnostics- Cost-Effectiveness of Frax with or without Pulse-Echo Ultrasound Measurement of Bone Mineral Density and DXA on Demand

    Nov 1, 2013, 00:00

  • Emerging Cardiovascular Events Associated with Targeted Anticancer Drugs. Preliminary Results of a Care Line’s Program Based on Audit Vigilance in a Private Health Care in Brazil

    Nov 1, 2013, 00:00

  • The Impact of the Polish Human Insulin (Gensulin) on Public Payer’s Expenditure in 2001-2013

    Nov 1, 2013, 00:00

  • Empirical Therapy for Respiratory Tract Infections in an Era of Increasing Antimicrobial Resistan A Decision and Cost Analysis

    Nov 1, 2013, 00:00

  • Impact of Recommended Pharmaceuticals on Cancer Mortality- Analysis of Real-Life Data

    Nov 1, 2013, 00:00

  • Simulating Patient Populations – Difficulties in Controlling the Roll of the Dice

    Nov 1, 2013, 00:00

  • Review of Cost of Diabetes Complications in Four European Countries

    Nov 1, 2013, 00:00

  • The Cost of Specialized Hospital Care for Patients with Diabetic Foot Ulcers in Russia

    Nov 1, 2013, 00:00

  • New Estimates of the Direct Medical Cost of Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sequences of Biologic Treatments for Moderate-To-Severe Psoriasis in Finland

    Nov 1, 2013, 00:00

  • Estimated Cost Effectiveness of Lower-Dose Submicron Diclofenac Compared with Traditional Diclofenac in Brazil

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial- Results from Four Major Cities in ...

    Nov 1, 2013, 00:00

  • Efficacy and Safety of New Anticoagulants in the Treatment of Atrial Fibrillation- A Health Technology Assessment

    Nov 1, 2013, 00:00

  • Comparative Evaluation of the Appropriateness of the Prescribing in Geriatrics Inpatients Using Beers Criteria 2012 and 2003

    Nov 1, 2013, 00:00

  • Analysis of Consumption of Diuretics in Serbia from 2006 to 2010

    Nov 1, 2013, 00:00

  • Estimating the Social Distribution of Health in England

    Nov 1, 2013, 00:00

  • Results from the “Autor” Study, a European Observational Study in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2013, 00:00

  • The Qualitative Profile of the Coverage Complaints Made By Health Plan Users to the Federal Regulatory Agency for Private Health Insurance and Plans (ANS)

    Nov 1, 2013, 00:00

  • Costos Asociados a Neumonía Severa Y Tuberculosis En Pacientes Con Artritis Reumatoide Que Han Recido Tratamiento Con Terapia Biologica Anti-TNF

    Nov 1, 2013, 00:00

  • A 10-Year Review of the Canadian Common Drug Review- Pharmaceutical Manufacturers’ Success Rate

    Nov 1, 2013, 00:00

  • Current Status and Evidence of Effects of E-Prescribing Implementation in United Kingdom, Italy, Germany, Denmark, Poland and United States

    Nov 1, 2013, 00:00

  • Baseline Characteristics and Vitreoretinal Interface Features in Patients with Vitreomacular Traction and Macular Hole from the MIVI-TRUST Clinical Program

    Nov 1, 2013, 00:00

  • Quality of Life Outcomes in Multiple Sclerosis- A Review of the Literature

    Nov 1, 2013, 00:00

  • Health Economic Benefits of Sensor Augmented Insulin Pump Therapy in Colombia

    Nov 1, 2013, 00:00

  • Prometex - Promevoz, Tool Support of Pharmaceutical Care for the Scope of Proper Adhesion in Colombia, 2009-2012

    Nov 1, 2013, 00:00

  • Generating the Cost-Effectiveness Frontier When Costs and/or Benefits Are Correlated Across Strategies

    Nov 1, 2013, 00:00

  • Market Access Risk Scoring- A Unified Framework for Cross Country Comparison of Diverse Market Access Systems and Processes

    Nov 1, 2013, 00:00

  • Exploring the Burden of Illness of Hereditary Angioedema in the United Kingdom

    Nov 1, 2013, 00:00

  • An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Measuring Health-Related Quality of Life by Experiences- The Experience Sampling Method

    Nov 1, 2013, 00:00

  • Mechanism of Coordinated Access to Orphan Drugs

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation Acceptability of Clopidogrel Versus Acetylsalicylic Acid in Patients with Cardiovascular Disease for Stroke Prevention in Ukraine

    Nov 1, 2013, 00:00

  • Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia

    Nov 1, 2013, 00:00

  • Differential Diagnosis of Leg Ulcers – Medical and Health Economics Aspects

    Nov 1, 2013, 00:00

  • Health Related Quality of Life and Device-Acceptance in Patients with Implantable Cardioverter-Defibrillators and Telemonitoring

    Nov 1, 2013, 00:00

  • Cohort Analysis Assessing Health Care Costs Associated with Obesity at Various Places of Service in Employed Adults

    Nov 1, 2013, 00:00

  • The Funding of Orphan Medicines in Europe- Payers Achilles’ Heel?

    Nov 1, 2013, 00:00

  • Additional Investments, Added Value, Real World Evidence and Additional Clinical Benefit in the Context of Subgroups of Special Interest

    Nov 1, 2013, 00:00

  • Nurses’ Preferences for Bone Metastases Treatments in the United States

    Nov 1, 2013, 00:00

  • Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine Compared to Other Regimens in the Canadian Health Care System

    Nov 1, 2013, 00:00

  • How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?

    Nov 1, 2013, 00:00

  • Economic Evaluation of Collagenase Versus Hydrogel Dressings for Chronic-Wound Treatment from the Public Payer Perspective

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization Program

    Nov 1, 2013, 00:00

  • Estimating Health State Utilities for Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL) in Mexico and Brazil

    Nov 1, 2013, 00:00

  • Informing the Affordability of Vaccines with Different Health Care Financing Mechanisms

    Nov 1, 2013, 00:00

  • The Global Burden, Incidence, and Prevalence of Chronic Hepatitis C

    Nov 1, 2013, 00:00

  • C-Quality- A Cost and Quality of Life Pharmacoeconomic Analysis of Antidepressants in Major Depressive Disorder in Italy

    Nov 1, 2013, 00:00

  • Hospital Admissions Related to Tuberculosis in Brazil- Epidemiological and Economic Profile, from the Public Health Care Perspective

    Nov 1, 2013, 00:00

  • Drug Distribution Strategies Cost in Brazil

    Nov 1, 2013, 00:00

  • Implications of Non-Adherence to Phosphate Binders on Patients’ Phosphate Levels

    Nov 1, 2013, 00:00

  • Evidence Thresholds in the Absence of Effective Alternatives- The Case of Intermittent Compression in Critical Limb Ischemia

    Nov 1, 2013, 00:00

  • Three Years of the Gefitinib UK Single Patient Access (SPA) Scheme- Duration of Treatment for Patients with EGFR Mutation Positive NSCLC in NHS Clinical Practice

    Nov 1, 2013, 00:00

  • Co-administration of Antipsychotics and Anti-dementia Drugs in Austria

    Nov 1, 2013, 00:00

  • Bone Evaluation Study (BEST)- Prevalence and Treatment Rates of Male Patients with Osteoporosis (OP) in Germany

    Nov 1, 2013, 00:00

  • Value-Based Pricing in the UK and Potential Patient Access Hurdles to Innovative Drugs

    Nov 1, 2013, 00:00

  • Introducing the ENCePP Working Group (WG) on Health Technology Assessment (HTA)- Enhancing the Generation of Additional Evidence for HTA Processes

    Nov 1, 2013, 00:00

  • Evidence-Based Methods in Food Sciences and Nutrition

    Nov 1, 2013, 00:00

  • Use of Diuretics in Serbia in the Period from 2007 to 2011 Year

    Nov 1, 2013, 00:00

  • Pharmacoeconomics of Cervarix Vaccines Against Human Papilloma Virus in the Republic of Kazakhstan

    Nov 1, 2013, 00:00

  • Review of Meta-Analysis Methods for Multinomial Data

    Nov 1, 2013, 00:00

  • Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in the United States

    Nov 1, 2013, 00:00

  • Costs of Dengue Control and Prevention Program in Brazil

    Nov 1, 2013, 00:00

  • Estudio De Costo/Utilidad Del Tratamiento Habitual De La Artritis Reumatoidea Mas Etanercept Versus Tratamiento Habitual Más Otros Biológicos Del Mercado Chileno Y Versus Tratamiento Habitual Sin Biológicos

    Nov 1, 2013, 00:00

  • Examination of Pelvic Floor Muscle Function After Pelvic Floor Muscle Training and Using Cube Pessary

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Linezolid and Vancomycin in Patients with Complicated Skin and Soft-Tissue Infections Caused by Methicilin-Resistant Staphylococcus in Portugal

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Peculiarities of Thyroid Disease Treatment in Ukraine

    Nov 1, 2013, 00:00

  • Uncertainty Quantification of Large-Scale Health Economic Simulation Models

    Nov 1, 2013, 00:00

  • Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in South Asian Population Living in Europe- A Systematic Review

    Nov 1, 2013, 00:00

  • Analysis of Spanish Generic Medicines Market- Recommendations to Enhance Long-Term Sustainability

    Nov 1, 2013, 00:00

  • Applied Comparison of Meta-Analysis Techniques

    Nov 1, 2013, 00:00

  • Health Care Resources Utilization and Associated Costs in Patients with COPD with or without Asthma- A Retrospective, Population-Based Observational Study

    Nov 1, 2013, 00:00

  • Harmonizing Measurement of Adherence Across the 4-Item and 8-Item Morisky Medication Adherence Scale Using Cross-Sectional Data from Patients Treated for Irritable Bowel Syndrome

    Nov 1, 2013, 00:00

  • Health Technology Assessment of Companion Diagnostic Biomarkers as Gatekeepers for Personalized Medicine Market Access

    Nov 1, 2013, 00:00

  • A Evolução Da Rede Brasileira De Avaliação E Tecnologia Em Saúde

    Nov 1, 2013, 00:00

  • Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Prostate Cancer and Bone Metastasis from a United State Managed Care Organization Perspective

    Nov 1, 2013, 00:00

  • Accessing the Pharmaceutical Markets of Brazil, Russia, India and China

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Step-Down Strategy Versus Conventional Therapy in the Treatment of Nosocomial Pneumonia Caused by Gram Positive Bacteria in Mexico

    Nov 1, 2013, 00:00

  • Economic Evaluation of Pharmacological Treatments for Overactive Bladder

    Nov 1, 2013, 00:00

  • The Use of Biologic Drugs for the Treatment of Rheumatoid Arthritis in Italy

    Nov 1, 2013, 00:00

  • Examining the Burden of Illness of the United States Veteran Patients Diagnosed with Alzheimer’s Disease

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Injectable Atypical Long-Acting Antipsychotics for Chronic Schizophrenia in Poland

    Nov 1, 2013, 00:00

  • Long Term Analisys of the Hungarian Hospital Bed Capacities

    Nov 1, 2013, 00:00

  • Socio-Economic Impact of Alzheimer’s Disease in Gree Pilot Study

    Nov 1, 2013, 00:00

  • Cross-Markets Variability of Innovation Benefit’s Evaluations. How Italy Compares to France, Germany and the United States

    Nov 1, 2013, 00:00

  • How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?

    Nov 1, 2013, 00:00

  • Evaluation of Variable Relevance and Accessibility to Support Personalized Medicine in Breast Cancer

    Nov 1, 2013, 00:00

  • Evaluación Económica Del Uso De La Perfusión Aislada De Extremidad Con Tasonermia En Pacientes Con Sarcoma De Tejido Blando Irresecable

    Nov 1, 2013, 00:00

  • ISPOR 4th Latin America Conference Author Index

    Nov 1, 2013, 00:00

  • Prevelance of Hydeted Disease in Sugicaly Operated Patient in Some Libyan General Hospital

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden

    Nov 1, 2013, 00:00

  • Evaluación Costo-Efectividad Y De Valor Social De Un Programa De Intervención En Población Infantil En Situación De Vulnerabilidad, Rezago O Déficit En El Desarrollo Integral - Chile 2012

    Nov 1, 2013, 00:00

  • Estimating the Cost Impact of Switching from a Vial to a Pre-Filled Syringe Mode of Administration for the DTaA-IPV-Hib ‘5-In-1’ Vaccine in Infants

    Nov 1, 2013, 00:00

  • ¿Los Formularios Nacionales (Cuadros Básicos) Provocan Oligopolios E Incentivan a Tener Precios Altos?

    Nov 1, 2013, 00:00

  • Consumption of Biosimilar Drugs in Campania Region in the Years 2009-2012

    Nov 1, 2013, 00:00

  • Novel Market Access Models for Cancer Drugs

    Nov 1, 2013, 00:00

  • The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

    Nov 1, 2013, 00:00

  • Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients- Significant Increase of Transportation Needs and Home Visits

    Nov 1, 2013, 00:00

  • An Economic Evaluation of the Triple HCV Treatment Regimen for G1 Naïve Patients in the Greek Health Care System

    Nov 1, 2013, 00:00

  • Too Early or Too Late? Impact of Different Herpes Zoster Vaccine’s Waning Rates on Age-Specific Incremental Cost-Effectiveness Ratio

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life of Patients on Opiate Replacement Therapy

    Nov 1, 2013, 00:00

  • Effect of Smoking Status on Health Care Costs and Resource Utilization in Patients with Chronic-Obstructive-Pulmonary-Disease in Clinical Practi A Retrospective Nested Case-Control Economic Study

    Nov 1, 2013, 00:00

  • Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids- A Systematic Review and Indirect Treatment Comparison

    Nov 1, 2013, 00:00

  • Chronic Patients’ Perceptions About Generic Medicines in Gree Findings from a Cross Sectional Survey

    Nov 1, 2013, 00:00

  • Health Care Utilization Following Newly-Diagnosed Type-2 Diabetes in Sweden- A Follow-Up of 38,956 Patients in a Real Clinical Setting

    Nov 1, 2013, 00:00

  • Challenges in Modelling the Cost Effectiveness of Interventions in Cardiovascular Disease

    Nov 1, 2013, 00:00

  • The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Don’t Make Me Wait- The Variance Reduction Technique for Faster Monte Carlo Simulations in Cost Effectiveness Models on Web

    Nov 1, 2013, 00:00

  • Results from a Two-Stage Delphi Process to Identify Cardiometabolic Risk Factors in Adrenal Insufficiency Patients and Understand Current Treatment in Italy

    Nov 1, 2013, 00:00

  • Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto Económico

    Nov 1, 2013, 00:00

  • Impact of Medicare Part D on Prescription Use, Health Care Expenditures, and Health Services Utilization- National Estimates for Medicare Beneficiaries, 2002 to 2009

    Nov 1, 2013, 00:00

  • Are Public Subsidies Effective to Reduce Hospitalizations

    Nov 1, 2013, 00:00

  • Rationale for Initiating and Switching Biologic Therapy in Patients with Rheumatoid Arthritis- Results of a European Chart Review Study

    Nov 1, 2013, 00:00

  • The Impact of Public Formularies Guidelines on Community Acquired Pneumonia (CAP) Drugs in Mexico

    Nov 1, 2013, 00:00

  • The Impact of Comorbidities on Utility Changes in Lower-Limb Osteoarthritis - Khoala Study

    Nov 1, 2013, 00:00

  • Evaluación De Costo-Efectividad De Certolizumab Pegol Comparado Con Etanercept En El Tratamiento De Artritis Reumatoidea En Colombia

    Nov 1, 2013, 00:00

  • Analysis of Adverse Reactions of Medicine in Ukraine

    Nov 1, 2013, 00:00

  • The Use of Dexa Scans in Postmenopausal Osteoporosis Is Associated with Reduced Long Term Fracture Risk

    Nov 1, 2013, 00:00

  • Pharmacoepidemiological Study of HMG CoA Reductase Inhibitor Prescribing- Impact of Generic Prescribing on Cost

    Nov 1, 2013, 00:00

  • Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality- A European Overview

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Evaluation of Intravenous Ferric Carboxymaltose and Iron Sucrose in Correction of Preoperative Anaemia in Patients Undergoing Major Elective Surgery

    Nov 1, 2013, 00:00

  • Reduction in Fixation Time and Related Surgical Stress with the Use of Ethicon Securestrap™ Open Absorbable Strap Fixation Device in the Deployment of Intra-Peritoneal Onlay Mesh (IPOM) for Open Ventral Hernia Repair

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy

    Nov 1, 2013, 00:00

  • Acute Asthma Characteristics and Asthma Control in Latin America

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis (CUA) of Different Strategies to Treat Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Evaluating the Economic Impact of Technological Advances in Diagnostics- The Case of High Throughput Sequencing for Hereditary Breast Cancer

    Nov 1, 2013, 00:00

  • Costo Efectividad Del Antibiótico Oral Vs. Local En Mujeres No Gestantes Con Flujo Vaginal Sugestivo De Vaginosis Bacteriana En Colombia

    Nov 1, 2013, 00:00

  • Clinical and Cost-Effectiveness of Non-Pegylated Liposomal Doxorubicin for Non-Hodgkin Lymphoma- A Systematic Review

    Nov 1, 2013, 00:00

  • Self-Reported Health Status and EQ-5D-3L Values of the Argentine Population- Comparing 2005 Versus 2009 National Risk Factor Surveys

    Nov 1, 2013, 00:00

  • Economic Burden of Inpatient Post-Admission Dehydration – Retrospective Database Analysis in Us

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis (CUA) of Belimumab (BEL) in the Treatment of Adult Patients with Active, Autoantibody-Positive Systemic Lupus Erythematosus (SLE)

    Nov 1, 2013, 00:00

  • Overview of Coverage with Evidence Development in Sweden

    Nov 1, 2013, 00:00

  • Effect of Antiviral Treatment Rates on the Predicted Future Burden of Genotype-1 Chronic Hepatitis C in the United Kingdom

    Nov 1, 2013, 00:00

  • Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study

    Nov 1, 2013, 00:00

  • An Analysis of the Cost Effectiveness of Left Atrial Appendage Closure for the Prevention of Stroke in Patients with Atrial Fibrillation and Absolute Contraindications to Warfarin Therapy

    Nov 1, 2013, 00:00

  • The Relationship Between Scientific Research, Clinical Trials and FDA Drug Approval

    Nov 1, 2013, 00:00

  • Correlating Cost Effectiveness Output with Patient Level Data Input Via the IMS Core Diabetes Model (CDM)

    Nov 1, 2013, 00:00

  • Stroke Prevention in Non-Valvular Atrial Fibrillation- Systematic Review of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Routine Infant Vaccination Strategies in Russia- An Economic Evaluation

    Nov 1, 2013, 00:00

  • Is the Use of Esomeprazole in Gastroesophageal Reflux Disease a Cost-Effective Option in Poland?

    Nov 1, 2013, 00:00

  • Translation and Validation of Hindi Version of Diabetes Quality of Life – Measure (DQOL-M) in Indian Type 2 Diabetes Patients

    Nov 1, 2013, 00:00

  • Beyond Patent Expiry- Development of a Model for Pricing Generic Drugs in South Africa

    Nov 1, 2013, 00:00

  • Estimating the Association Between the Oxford Hip Score (OHS) and EQ-5D Utility Values Using Direct and Response Mapping Methods

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Egyptian Diabetic Patients

    Nov 1, 2013, 00:00

  • RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)

    Nov 1, 2013, 00:00

  • Systematic Literature Reviews at the Heart of Health Technology Assessment- A Comparison Across Markets

    Nov 1, 2013, 00:00

  • A Bayesian Dynamic Model of Asthma in the Real Life

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

    Nov 1, 2013, 00:00

  • Características Socioeconómicas De Pacientes Con Enfermedad Vascular Cerebral Y Antecedentes De Tabaquismo Tratados En Un Hospital De Tercer Nivel De México

    Nov 1, 2013, 00:00

  • Relative Clinical and Economic Value of Ipilimumab in Mexico

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Medication Adherence Enhancing Interventions- A Systematic Review

    Nov 1, 2013, 00:00

  • Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis

    Nov 1, 2013, 00:00

  • Using a “Standards of Care Economic Model” to Quantify Barriers and Potential Solutions to Providing Optimal Guideline-Driven Care to Patients with Diabetes Mellitus in the United States

    Nov 1, 2013, 00:00

  • Improvement in Disease Activity Scores Associated with Early Versus Late Initiation of Biologic Therapy in Patients with Rheumatoid Arthritis- Results of a European Chart Review Study

    Nov 1, 2013, 00:00

  • Utilization Patterns for Treatment with Strong Opioids for Chronic Back Pain in Germany

    Nov 1, 2013, 00:00

  • Osteotomia De Acortamiento Radial En La Enfermedad De Kienbock (Seguimiento De 5 Años)

    Nov 1, 2013, 00:00

  • Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Public Health Care System in Brazil- Results from a Retrospective Analysis of an Administrative Database

    Nov 1, 2013, 00:00

  • Characteristics of Hospitalizations Due to an Episode of Relapse in Multiple Sclerosis Brazilian Patients- A Retrospective Administrative Claims Analysis Under the Public Payer Perspective

    Nov 1, 2013, 00:00

  • Risk Factors Influencing the Viral Transmission and the Potential Development of HPV-Induced Pathologies

    Nov 1, 2013, 00:00

  • Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in Hungary

    Nov 1, 2013, 00:00

  • Long-Term Outcomes of Chronic Hepatitis C in the Population of Newly Diagnosed Russian Patients

    Nov 1, 2013, 00:00

  • Doubling of Health Care Costs Among Asthma Patients with COPD Diagnosis and Its Associated Co-Morbidities in a Claims Database in the United States

    Nov 1, 2013, 00:00

  • Quality Assurance of Fourth Hurdle Concerning to Drugs and Medical Devices

    Nov 1, 2013, 00:00

  • The Importance of Safety Aspects in the Amnog Process in Germany- Is the G-Ba Assessment Consistent with That of the CHMP?

    Nov 1, 2013, 00:00

  • Continuos Renal Replacement Therapy Versus Intermittent Hemodialysis- Systematic Review on Patient-Oriented Outcomes

    Nov 1, 2013, 00:00

  • Economic Impact of Stroke Episode in Patients Previous Diagnosed with Atrial Fibrillation in Private Health System in Brazil

    Nov 1, 2013, 00:00

  • The Short-Term Impact of Particulate Matter Exposure on the Risk of Prescription of Cardiorespiratory Drugs in Italy

    Nov 1, 2013, 00:00

  • Compliance with Preventive Recommendations in Primary Care and Rate of Potentially Avoided Hospitalizations by Diabetes, Chronic Heart Failure or Chronic Pulmonary Obstructive Disease

    Nov 1, 2013, 00:00

  • Comparison of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Atrial Fibrillation in Ireland Over 5 Years

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

    Nov 1, 2013, 00:00

  • Nutrieconomic Exploratory Assessment of a Daily Consumption of Plant Sterols-Enriched Dairy Products on Statin’s Initiation Delay- A Consumer Perspective Approach

    Nov 1, 2013, 00:00

  • Aflibercept in Neovascular (Wet) Age-Related Macular Degeneration- An Analysis of the Payer Decision Landscape

    Nov 1, 2013, 00:00

  • Does It Matter? Discounting and Its Role in Analysing the Cost-Effectiveness of Preventative Interventions

    Nov 1, 2013, 00:00

  • Effects of the Occurrence of a First Cardiovascular Event on Statin Adherence in Type 2 Diabetes- A Matched Cohort Design

    Nov 1, 2013, 00:00

  • Driving After Drinking- Hospitalization, Mortality Rate, and Costs Pre and Post Prohibition in Rio De Janeiro, Brazil

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Expenditures of Incident Breast Cancer Patients in the Netherlands- Retrospective Analysis of Health Insurance Data

    Nov 1, 2013, 00:00

  • An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial

    Nov 1, 2013, 00:00

  • Cost Analysis of the Use of an Operating Room with Full-Rotation 3-D Intraoperative Imaging and Navigation in Different Spine Surgeries

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Las Pruebas Para La Tamización De Bacteriuria Asintomática Durante La Gestación

    Nov 1, 2013, 00:00

  • Are Israeli Adults Willing to Pay Higher Health Taxes for a Wider Coverage of Life-Extending Medications?

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in the United Kingdom

    Nov 1, 2013, 00:00

  • Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in Turkey- A Payor Perspective

    Nov 1, 2013, 00:00

  • Economic Evaluation of Universal Antenatal HIV Screening Compared with Current “At Risk” Policy in Israel

    Nov 1, 2013, 00:00

  • Budget Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France

    Nov 1, 2013, 00:00

  • Economic Impact Model of Lipegfilgastrim to Prevent Neutropenia in Cancer Patients in Spain

    Nov 1, 2013, 00:00

  • Statin Cost-Effectiveness in Patients with Previous Coronary Heart Disease- A Systematic Review of the Cost-Effectiveness Analysis Derived from Single Randomised Clinical Trials

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Statins for Primary Prevention in Newly Diagnosed Type 2 Diabetes Patients in the Netherlands

    Nov 1, 2013, 00:00

  • Comparison of the Prices Used in the Manufacturers’ Budget Impact Analyses and the Prices from Reimbursed Drugs List

    Nov 1, 2013, 00:00

  • Costs Associated with Cold Chain Used to Store and Transport Thermally Unstable Antiretroviral Drugs

    Nov 1, 2013, 00:00

  • The Adoption of Health Technologies- A Survey of Brazilian Policy Makers

    Nov 1, 2013, 00:00

  • Baseline Characteristics, Weight and Glycaemic Change Among Patients in the United Kingdom with Type 2 Diabetes Mellitus (T2DM) Prescribed a New Antidiabetic Treatment Class in a Real World Setting

    Nov 1, 2013, 00:00

  • Economic Activity of Cancer Survivors in Poland

    Nov 1, 2013, 00:00

  • Análise De Impacto Orçamentário Do Oclusor Septal Percutâneo Para O Fechamento De Comunicação Interatrial (CIA) Do Tipo Ostium Secundum

    Nov 1, 2013, 00:00

  • Usefulness of the Hypoglycemia Perspectives Questionnaire (HPQ) in Management of Patients with Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Comparative Efficiency Research- Meta-Analysis of Cost-Effectiveness Studies

    Nov 1, 2013, 00:00

  • It Application for Post Marketing Drug Registries

    Nov 1, 2013, 00:00

  • The Review of Publications of Pharmacoeconomic Research in Russia During 2007-2012

    Nov 1, 2013, 00:00

  • Utility and Resource Use of an Australian Population of Psoriasis Patients

    Nov 1, 2013, 00:00

  • Protective Factors for University Students’ Health

    Nov 1, 2013, 00:00

  • Approaches for Estimating Burden of Pneumococcal and Rotavirus Diseases- Conceptual Framework and Systematic Review

    Nov 1, 2013, 00:00

  • Identification and Qualitative Assessment of Real World Data Sources- Example of Lymphoma and Multiple Myeloma in Europe

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Lacosamide Compared with Standard of Antiepileptic Care Based on Clinical Practice Data

    Nov 1, 2013, 00:00

  • Variance Reduction Through Antithetic Variates as a Means of Developing Complex VBA Models with Reasonable Computation Times

    Nov 1, 2013, 00:00

  • Crossover Adjustment in Oncology Trials Using a Rank Preserving Structural Failure Time Model (RPSFTM)- Wrapping Bootstraps Around Estimates of Life Expectancy for CE Models

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Apomorphine in the Treatment of Advanced Parkinson Disease in the UK and Germany- Results from a Multicounty Decision Analytic Model

    Nov 1, 2013, 00:00

  • Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol- 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analyses of Natalizumab for 1st Line Versus Interferon Beta-1a 44 Mcg in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis Patients in Brazil

    Nov 1, 2013, 00:00

  • Evaluation of the Length of Hospital Stay for Patients with Atrial Fibrillation

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Las Vacunas Neumocócicas Conjugadas 10 Y 13 Valente Para Niños En Antioquía, Colombia

    Nov 1, 2013, 00:00

  • ¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios Científicos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?

    Nov 1, 2013, 00:00

  • Bis Sensor Versus Conventional Anesthetic Monitoring- Systematic Review on Patient-Oriented Outcomes

    Nov 1, 2013, 00:00

  • Assessing Product Safety via Patient Based Active Surveillance (AS)- A Study in 30.000 Women Using Hormone Replacement Therapy (HRT)

    Nov 1, 2013, 00:00

  • Time Savings with Once-Monthly C.E.R.A.- A Time and Motion Study Conducted in 13 Hemodialysis Centres in Italy

    Nov 1, 2013, 00:00

  • Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)

    Nov 1, 2013, 00:00

  • Recent Trends in Hospital Costs, Length of Stay, and Mortality Associated with Pediatric Meningococcal Disease in the United States

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France

    Nov 1, 2013, 00:00

  • Health Technology Assessment- Is It the Right Piece for the Jordanian Health Care Puzzle?

    Nov 1, 2013, 00:00

  • Podcasts as a Learning Tool in a Research Methods Course for Pharmacy Students

    Nov 1, 2013, 00:00

  • Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer- An Italian Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Multi-state Statistical Modelling to Quantify an Individual-based Micro Simulation Model for Radiotherapy Treatment in Lung Cancer Patients

    Nov 1, 2013, 00:00

  • Patient Reported Outcomes Asssesment of Thai Chronic Stable Angina Pectoris(CSAP)

    Nov 1, 2013, 00:00

  • Ruling Out IBD in the United Kingdom and Spain- Is the Usage of F-Calprotectin in Primary Care Cost-Effective?

    Nov 1, 2013, 00:00

  • Evolución Del Consumo Y Ventas De Antibióticos En Chile 1998-2012

    Nov 1, 2013, 00:00

  • Incretin Therapy for Patients with Type 2 Diabetes in Spain- A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin

    Nov 1, 2013, 00:00

  • Attitude of Parents Towards Obligatory and Recommended Childhood Vaccination

    Nov 1, 2013, 00:00

  • The Sustainability of Irish Pharmaceutical Expenditure

    Nov 1, 2013, 00:00

  • International Normalized Ratio (INR) Monitoring and Percent Time in Therapeutic INR Range (TTR) Have Impact on Patient’s Quality of Life? Application of Beta Regressions in a Prospective 3 Months Setting

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

    Nov 1, 2013, 00:00

  • Clinical Outcome Assessments in FDA Oncology Labels Since 2010

    Nov 1, 2013, 00:00

  • Treatment Patterns of Atrial Fibrillation (AF) in Latin America

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Measurement of Health-Related Quality of Life Using EQ-5D

    Nov 1, 2013, 00:00

  • Análisis De La Carga Financiera De Las Principales Enfermedades Reumatológicas

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Capsule Endoscopy in Screening for Colorectal Cancer in Japan

    Nov 1, 2013, 00:00

  • Can Administrative Data Predict Chemotherapy Adverse Events?

    Nov 1, 2013, 00:00

  • Introduction of an Infliximab Biosimilar (CT-P13)- A Five-Year Budget Impact Analysis for the Treatment of Rheumatoid Arthritis in Ireland

    Nov 1, 2013, 00:00

  • Quality of Care for Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • How Well Do We Understand the Economic Burden Associated with Dementia? A Focus on Trends in Care Home Costs and Future Perspectives in the United Kingdom

    Nov 1, 2013, 00:00

  • Feasibility of a Survey on the Willingness-To-Pay for Colorectal Cancer Screening Using Social Networks

    Nov 1, 2013, 00:00

  • Introduction of Innovations into the German Statutatory Reimbrusment System – Factors for Success

    Nov 1, 2013, 00:00

  • Frequency of Lower Urinary Tract Symptoms in Men and Women in Hungary – Results of an Open Label Questionnaire Study from 2012

    Nov 1, 2013, 00:00

  • A Systematic Evaluation of Drug-Drug Interactions in Prescriptions; Facts and Comparisons

    Nov 1, 2013, 00:00

  • Adding a Reminder Short Message Service (SMS) Before and Tablet Computer During Clinic Improves Electronic Patient Reported Outcome Measures (ePROMS) Collection

    Nov 1, 2013, 00:00

  • Assessment of Patient Population with NSCLC by Stage, ECOG-PS, EGFR Mutation Status and Line of Therapy in Germany

    Nov 1, 2013, 00:00

  • Public Health Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France

    Nov 1, 2013, 00:00

  • Differences in Health Care Resource Utilization and Expenditures Among Schizophrenic Patients in the United States by Health Insurance Status, 2007-2008

    Nov 1, 2013, 00:00

  • Monitoring Health Processes in the Real World- An Italian Population Database Experience

    Nov 1, 2013, 00:00

  • Methodological Challenges in Comparing Topical Therapies in Dermatology in the Absence of Head to Head Studies

    Nov 1, 2013, 00:00

  • Quality of Life in Patients with Multiple Sclerosis in Slovakia

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Para El Manejo Farmacológico De La Hemofilia a Severa En 5 Entidades De Aseguramiento En Colombia

    Nov 1, 2013, 00:00

  • The Impact of Increasing Pain Severity on Impairment of Regular Daily Activities

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Various Combinations of Human Papillomavirus (HPV)-Based Primary Screening Testing, Including Genotyping for HPV 16/18, for Cervical Cancer Screening in Mexico

    Nov 1, 2013, 00:00

  • Medical Costs of Patients with Rheumatoid Arthritis and Association with Global Disease Activity in Turkey

    Nov 1, 2013, 00:00

  • Methodological Approaches for Modeling Cardiovascular Events in Cost-Effectiveness Analyses Based on Outcome Trials

    Nov 1, 2013, 00:00

  • A Flexible Multi-State Modelling Framework for the Simulation of Cancer Progression and Cancer Care

    Nov 1, 2013, 00:00

  • Antibiotic Utilization in Complicated Urinary Tract Infection in a Tertiary Care Teaching Hospital in South India

    Nov 1, 2013, 00:00

  • Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH)- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Scandinavian Drug Reimbursement and Coverage Decisions- The Role of HTA

    Nov 1, 2013, 00:00

  • Recommendations for the Successful Linguistic Validation of Clinical Outcome Assessments for Limited Patient Populations

    Nov 1, 2013, 00:00

  • External Validation of the Syreon Diabetes Model

    Nov 1, 2013, 00:00

  • Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes

    Nov 1, 2013, 00:00

  • Graphic Health Warnings on Cigarette Packs in Qatar- Pre-Implementation Awareness and Perception Among the General Public

    Nov 1, 2013, 00:00

  • Development of Novel Imaging Tests to Select Patients for Individualized Therapies- Are They Worth Further Investment?

    Nov 1, 2013, 00:00

  • Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors- The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

    Nov 1, 2013, 00:00

  • Real Life Effects of Liraglutide Supports Those Shown in RCTs

    Nov 1, 2013, 00:00

  • Mobile Phone Use in Patient Reported Outcomes – A Literature Search

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of the Polish Version of “Disabilities of the Arm, Shoulder and Hand” (DASH) and Quickdash Questionnaires

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ivabradine in Chronic Heart Failure in Greece

    Nov 1, 2013, 00:00

  • Costos Asociados a Eventos Cardiovasculares En Pacientes Con Artritis Reumatoide Afiliados Al Régimen Subsidiado En Colombia

    Nov 1, 2013, 00:00

  • Different Injection Frequencies of Basal Insulins in Type 2 Diabetes Patients Under Real-Life Conditions- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ivabradine for Chronic Heart Failure NYHA II to IV Class with Systolic Dysfunction in Ireland

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Paricalcitol in End Stage Chronic Kidney Disease Secondary Hyperparathyroidism Patients on Dialysis, in Brazil

    Nov 1, 2013, 00:00

  • A Systems-Thinking Approach for the Health Care Industry- Strategies and Insights for Biopharma, Payers and Providers

    Nov 1, 2013, 00:00

  • Cost Analysis for Patients Hospitalised for Heart Failure in Germany

    Nov 1, 2013, 00:00

  • Does Europe Reward Reformulations? A Data Driven Analysis of Value Preservation Through Reformulation

    Nov 1, 2013, 00:00

  • Three TNF-A-Inhibitors for Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Economic Burden of Patients with Painful Diabetic Neuropathy in Europe- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Paediatric Gastroenteritis- Disease Burden, Cost and Loss of Productivity of Malaysian and Vietnamese Parents

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk Late Preterm Infants in the Netherlands

    Nov 1, 2013, 00:00

  • Patients Preferences for Long-Term Treatment After Acute Coronary Syndrome- A Discrete-Choice Experiment and Analytic Hierarchy Process

    Nov 1, 2013, 00:00

  • Developing Personalized Medicine Drugs - Incentives for Pharmaceutical Companies

    Nov 1, 2013, 00:00

  • The Cost of Clostridium Difficile Infection in Hungary

    Nov 1, 2013, 00:00

  • Costs of COPD in Fran A National Database Analysis

    Nov 1, 2013, 00:00

  • Pricing and Reimbursement System of Orphan Drugs in the Czech Republic

    Nov 1, 2013, 00:00

  • Effectiveness of Montelukast on Asthma Control in Infants- Methodology of a Claims Data Study

    Nov 1, 2013, 00:00

  • Evaluating Fatigue in Fibromyalgia- Development and Validation of the Daily Diary of Fatigue Symptoms in Fibromyalgia (DFS-Fibro)

    Nov 1, 2013, 00:00

  • Microsimulation or Cohort Modelling? A Case Study in Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2013, 00:00

  • Estimating Market Potential for Biosimilar Introduction

    Nov 1, 2013, 00:00

  • Barriers Underlying Limited Utilisation of Vaccines Throughout Life (Lifespan Immunisation)

    Nov 1, 2013, 00:00

  • Using an Excel Calculator to Estimate Ankylosing Spondylitis Costs in Turkey

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Aspects of Chronic Pain Management in Russian Cancer Patients

    Nov 1, 2013, 00:00

  • Preliminary Testing of the Sagit Tool- A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice

    Nov 1, 2013, 00:00

  • Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study

    Nov 1, 2013, 00:00

  • Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence Levels

    Nov 1, 2013, 00:00

  • Budget Impact of Paliperidone Palmitate in Austria

    Nov 1, 2013, 00:00

  • Impact of Comorbidity Burden on Real-World Health Care Costs of Rheumatoid Arthritis Patients in Turkey

    Nov 1, 2013, 00:00

  • The E-Health Impact Questionnaire- Developing a Tool to Measure the Effects of Using Health-Related Websites

    Nov 1, 2013, 00:00

  • Further Validation of a New Questionnaire to Measure Satisfaction with Medical Care in Patients with Atrial Fibrillation (SAFUCA) in Spain

    Nov 1, 2013, 00:00

  • Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at Very High Cardiovascular Risk in the United Kingdom- Results from a General Practice Population Study

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Diagnostico Etiológico Con Pruebas Rapidas Vs. Sindromico En Mujeres No Gestantes Con Sintomas De Infección Cervical En Colombia

    Nov 1, 2013, 00:00

  • Analysis of the IQWIG Comments on the Evidence Searches of Dossiers in the German Amnog Process

    Nov 1, 2013, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Hip and Thigh Injuries in Hungary in 2009

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Insulin Degludec Compared with Current Standard of Care in the Management of Type 1 and Type 2 Diabetes Mellitus in the Spanish Health System

    Nov 1, 2013, 00:00

  • Disposición a Pagar Y Análisis De Conjoint Para Determinar Las Preferencias Por Los Productos Medley En México

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Ipilimumab for the Treatment of Advanced Melanoma in the Veneto Region, Italy

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Bendamustine-Rituximab in First-Line Indolent NHL- A Patient-Level Simulation

    Nov 1, 2013, 00:00

  • Estimation of the Number of Cases of Nosocomial Skin and Soft Tissue Infection in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico

    Nov 1, 2013, 00:00

  • Cost Reduction Associated with Use of Subglottic Aspiration to Reduce Ventilator-Associated Pneumonia in Turkey

    Nov 1, 2013, 00:00

  • Etanercept 25 Mg Once Weekly Could Be a Cost-Effective Option for Rheumatology Patients in Sustained Clinical Remission

    Nov 1, 2013, 00:00

  • Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care Setting

    Nov 1, 2013, 00:00

  • Treatment and Outcome Analysis of Rodenticide Poisoning in Tertiary Care Hospital in South India

    Nov 1, 2013, 00:00

  • Psychoactive Drug Use, Polypharmacy and Co-Morbidities in Newly Diagnosed Patients with Pervasive Development Disorder in the Province of Quebec

    Nov 1, 2013, 00:00

  • Evaluation of Associations Among Biomarkers, Correlates and Treatment Efficacy in Clinical Studies in Patients Diagnosed with Non-Psychotic Major Depressive Disorder- A Literature Review

    Nov 1, 2013, 00:00

  • Disease Status, Treatments and Outcomes of Patients with Ankylosing Spondylitis Receiving Their First Biologic in the United States and European Union

    Nov 1, 2013, 00:00

  • A Unified Methodological Framework for the Economic Evaluation of Therapeutic Medical Devices

    Nov 1, 2013, 00:00

  • Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate

    Nov 1, 2013, 00:00

  • Direct and Indirect Costs of MS in Ireland

    Nov 1, 2013, 00:00

  • Economic Consequences of Nonalcoholic Steatohepatitis in the United States

    Nov 1, 2013, 00:00

  • Comparative Responsiveness of Direct and Mapped SF-6D Preference-Based Measures in Colorectal Cancer

    Nov 1, 2013, 00:00

  • Assessment of Adverse Events By Using Trigger Tools in Surgery Department of an Indian Tertiary Care Teaching Hospital

    Nov 1, 2013, 00:00

  • Quality of Life (QOL) During Treatment of Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Treatment Adherence and Costs in Multiple Sclerosis- A Narrative Review of the Literature

    Nov 1, 2013, 00:00

  • La Utilidad Predictiva Del Euroscore Puede Ser Mejorada Al Adicionar Valores De Peptido Natriurético Tipo B O De Hemoglobina

    Nov 1, 2013, 00:00

  • Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure- Application in Parkinson’s Disease

    Nov 1, 2013, 00:00

  • Mode Equivalence of Interactive Voice Response (IVR) and Paper Versions of the Brief Pain Inventory (BPI) “Worst Pain” Item in Metastatic Castrate Resistant Prostate Cancer (mCRPC) Evaluated Conceptually Using Qualitative Methods

    Nov 1, 2013, 00:00

  • Physicians’ Preferences for Bone Metastases Treatments in the United States

    Nov 1, 2013, 00:00

  • Derivation of Severity Index for Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Estimation of Generic Utilities in Spanish Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2013, 00:00

  • Pricing and Reimbursment of Pharmaceuticals in Iran

    Nov 1, 2013, 00:00

  • Evaluating the Cost Effectiveness of Gene Expression Profiling and Immunohistochemistry Tests

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sugammadex for Routine Reversal of Neuromuscular Blockade, with Extubation at a TOF Ratio of 0.9, in Anaesthetised Patients Undergoing Elective Surgery in England and Wales

    Nov 1, 2013, 00:00

  • Retrospective Costing Study to Estimate Burden of Heart Failure in Spain

    Nov 1, 2013, 00:00

  • Evaluate the Status of Pharmacoeconomic Research Development in China from 2002 to 2013

    Nov 1, 2013, 00:00

  • Physicians’ Preferences for Bone Metastases Treatments in France, Germany and the United Kingdom

    Nov 1, 2013, 00:00

  • COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

    Nov 1, 2013, 00:00

  • Mothers’ Own Milk for the Feeding of Preterm Infants- A Systematic Literature Review

    Nov 1, 2013, 00:00

  • Outpatient Medical Costs, Indirect Costs, and Family Burden of Osteoporosis Fracture in China

    Nov 1, 2013, 00:00

  • Effect of Health Spending, Income Inequality and Margination Index on the Efficiency of the Health System in Mexico

    Nov 1, 2013, 00:00

  • Impacto Do Uso Do Microdebridador Nos Desfechos E Custos Nas Cirurgias Endoscópicas Nasais

    Nov 1, 2013, 00:00

  • Regulatory and General Epidemiological Knowledge About Rare Diseases and Access to Treatment for Rare Diseases- Health Professionals’ View in Serbia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Diagnostic Tests in the Work-Up of Patients with Intermediate Risk of Developing Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Regulating the Access to an Adequate and an Integral Assistance in Brazilian Private Health Plans

    Nov 1, 2013, 00:00

  • Cost Analysis of a Fibrin Sealant Patch for Mild, Moderate and Problematic Soft Tissue Surgical Bleeding- A Hospital Perspective

    Nov 1, 2013, 00:00

  • Health Technology Assessment of High-Value Therapies

    Nov 1, 2013, 00:00

  • Uncertainty and Cost-Effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • Testing the Eunethta Internal Validity of Randomized Controlled Trials Guideline and Tool in Hungary

    Nov 1, 2013, 00:00

  • Modeling the Impact of Disease Modifying Treatment on Time to Disability Health States in Multiple Sclerosis- An Evaluation of Oral Therapies Through Indirect Comparisons of 6-Month Confirmed Disability Progression

    Nov 1, 2013, 00:00

  • Validation of Accept, a New Generic Measure to Assess How Patients with Chronic Diseases Balance Between the Advantages and Disadvantages of Following the Recommended Treatment Regimen in Real-life

    Nov 1, 2013, 00:00

  • Bayesian Analysis of Malformation Outcome in Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy- An Indirect Comparison of Citalopram, Fluoxetine, Paroxetine, and Sertraline

    Nov 1, 2013, 00:00

  • The Impact of Daytime and Nocturnal Non-Severe Hypoglycaemic Events on People with Diabetes in Brazil

    Nov 1, 2013, 00:00

  • Cost Analysis of an Intensive Care Unit

    Nov 1, 2013, 00:00

  • Trends in the Cost-Effectiveness of Stroke Care

    Nov 1, 2013, 00:00

  • Cost-minimization Analysis of Dienogest Versus Gonadotrophin-releasing Hormone Analogues or Dydrogesterone for Endometriosis Treatment in Russia

    Nov 1, 2013, 00:00

  • Clinical and Cost-effectiveness of a Procalcitonin Test as a Prompt Indicator of Prodomol Meningococcal Disease in Febrile Children- Cost-effectiveness Analysis

    Nov 1, 2013, 00:00

  • Variability of Clinical Practice for Bariatric Surgery in Spain

    Nov 1, 2013, 00:00

  • Using Multi-Criteria Decision Analysis to Support Allocation Decisions in Large Translational Research Projects

    Nov 1, 2013, 00:00

  • Applicability of Japanese Health Care Database to Clinical Trial Planning for Dyslipidaemia Drug

    Nov 1, 2013, 00:00

  • Health Technology Assessment of Contrast-Enhanced Ultrasound (CEUS) Techniques

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Telaprevir in Combination with Peginterferon Alpha and Ribavirin in Previously Untreated Patients with Chronic Hepatitis in a Romanian Setting

    Nov 1, 2013, 00:00

  • A Literature Review on the Humanistic and Economic Burden of Mineralocorticoid Excess Syndrome

    Nov 1, 2013, 00:00

  • Comparative Analysis of the Cost and Metabolic Control in Diabetic Children Using Insulin Pumps

    Nov 1, 2013, 00:00

  • The Impact of the Blind Bid Procedure in Hungary

    Nov 1, 2013, 00:00

  • Antithrombotic Strategies and Adverse Outcomes in Acute Coronary Syndrome and Atrial Fibrillation- A Community Study

    Nov 1, 2013, 00:00

  • Cost of Inpatient Management of Hypoglycaemia in France

    Nov 1, 2013, 00:00

  • Dual Back Translation Versus Single Back-Translation Methodology When Translating Patient Reported Outcomes (PRO)

    Nov 1, 2013, 00:00

  • How Does the Uncertainty Around the Expected ICER Affect Nice Decisions?

    Nov 1, 2013, 00:00

  • Development of an Interviewer-Administered Version of the Asthma Control Questionnaire (ACQ-IA) for 6-10 Year Old Patients in 11 Languages

    Nov 1, 2013, 00:00

  • Health Insurance Cost of Epilepsy in Hungary- A Cost of Illness Study

    Nov 1, 2013, 00:00

  • Treatment Disparity Among Patients Diagnosed with Depressive Disorder in Working Population Based on Claims Database in Japan

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in Brazil

    Nov 1, 2013, 00:00

  • ISPOR 16th Annual European Congress Author Index

    Nov 1, 2013, 00:00

  • The Impact of Amnog on Oncology Drugs

    Nov 1, 2013, 00:00

  • Análisis Del Impacto En La Demanda De Tecnologías Incluidas En El Plan De Beneficios Colombiano (POS) Posterior A Su Actualización En 2012

    Nov 1, 2013, 00:00

  • An Approach for Quantification of Patient Advocacy Group Input in the HTA Process

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia

    Nov 1, 2013, 00:00

  • Health Care Cost of Type 2 Diabetes Patients in Gree Sub-Population Analysis

    Nov 1, 2013, 00:00

  • Health Economic Modelling of Sequential Therapies for Rheumatoid Arthritis- A Systematic Review

    Nov 1, 2013, 00:00

  • Preference Structure of Clinicians in the Use of Electronic Medical Records; Quantifying the Relative Importance of Barriers and Facilitators of an Innovation

    Nov 1, 2013, 00:00

  • The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in Belgium

    Nov 1, 2013, 00:00

  • Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal Products

    Nov 1, 2013, 00:00

  • Can the Use of Social Media and Mobile Apps Improve Patient Knowledge of Disease and Health Outcomes? A Systematic Review

    Nov 1, 2013, 00:00

  • UTILITIES FOR TYPE 2 DIABETES MELLITUS AND ASSOCIATED COMPLICATIONS

    Nov 1, 2013, 00:00

  • Considering Economic Analyses in the Revision of the Preventive Vaccination Law- A New Direction for Health Policy-Making in Japan?

    Nov 1, 2013, 00:00

  • Comparing Quality of Life and Clinical Variables for the Prediction of Future Medical Events

    Nov 1, 2013, 00:00

  • Re-Establishing the Societal Value of Pediatric Combination Vaccines

    Nov 1, 2013, 00:00

  • The List of Medicines for COPD Treatment in State Formulary of Ukraine and Related Costs

    Nov 1, 2013, 00:00

  • The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium

    Nov 1, 2013, 00:00

  • The German Quota System as a Model for Biosimilar Cost Savings in Epoetin Treatment

    Nov 1, 2013, 00:00

  • Cost Analysis of Alprostadil (Prostavasin®) as Treatment for Patients with Peripheral Arterial Disease Stages III and IV Compared with Lumbar Sympathectomy in Mexico

    Nov 1, 2013, 00:00

  • Efecto De La Determinación De La Concentración Capilar De Proteína C Reactiva En La Tasa De Prescripción De Antibióticos Para El Tratamiento De Infección De Vías Respiratorias Altas (Análisis De Costo-Efectividad)

    Nov 1, 2013, 00:00

  • Nice STA Decisions- An Analysis of How Advice Differs Between Preliminary and Final Guidance

    Nov 1, 2013, 00:00

  • Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders

    Nov 1, 2013, 00:00

  • Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of Diabetes

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112 (current)
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »